<html xmlns:v="urn:schemas-microsoft-com:vml"
      xmlns:o="urn:schemas-microsoft-com:office:office"
      xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page1_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page1_files/editdata.mso">
<link rel=OLE-Object-Data href="./Page1_files/oledata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>McDowall</o:LastAuthor>
  <o:Revision>27</o:Revision>
  <o:TotalTime>1170</o:TotalTime>
  <o:Created>2004-12-20T11:52:00Z</o:Created>
  <o:LastSaved>2005-01-07T11:16:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>830</o:Words>
  <o:Characters>4731</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>39</o:Lines>
  <o:Paragraphs>9</o:Paragraphs>
  <o:CharactersWithSpaces>5810</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
h3
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:normal;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
pre
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Arial Unicode MS";}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1032"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='color:windowtext;text-decoration:
none;text-underline:none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1028" type="#_x0000_t75" style='width:141pt;
 height:45pt' o:ole="">
 <v:imagedata src="./Page1_files/image001.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=188 height=60
src="./Page1_files/image002.gif" v:shapes="_x0000_i1028"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Word.Picture.8" ShapeID="_x0000_i1028"
  DrawAspect="Content" ObjectID="_1166601789">
 </o:OLEObject>
</xml><![endif]--></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:36.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Phenylalanine hydroxylase<o:p></o:p></span></h1>

<h2 align=center style='text-align:center'><span style='font-style:normal'>By
Jennifer McDowall<o:p></o:p></span></h2>

<p class=MsoNormal><a href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb61_1.html"
title="Link to the structural features of phenylalanine hydroxylase"><span
style='text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shape
 id="_x0000_i1026" type="#_x0000_t75" style='width:108.75pt;height:28.5pt'>
 <v:imagedata src="./Page1_files/image003.png" o:title="PDB_original"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=145 height=38
src="./Page1_files/image004.gif" v:shapes="_x0000_i1026"><![endif]></span></a></p>

<p class=MsoNormal><a href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb61_1.html"
title="Link to the structural features of phenylalanine hydroxylase">To view
structure of Phenylalanine hydroxylase</a><span class=MsoHyperlink><o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText2><span style='mso-tab-count:1'>            </span>Amino
acids are the building blocks of proteins, and their sequence in a protein
determines the 3-dimensional shape and ultimately the function of that protein.<span
style="mso-spacerun: yes">  </span>Of the twenty amino acids commonly found in
nature, nine are considered to be “essential” in humans, because they cannot be
synthesised from other precursors, and therefore must be included in the diet.<span
style="mso-spacerun: yes">  </span>These essential amino acids are
phenylalanine, histidine, isoleucine, leucine, lysine, methionine, threonine,
tryptophan and valine.<span style="mso-spacerun: yes">  </span>Even though
these amino acids are deemed essential, their relative amounts in the
bloodstream must be tightly controlled.<span style="mso-spacerun: yes"> 
</span>For example, with phenylalanine (Phe), the accumulation of Phe can lead
to neurological damage, while too rapid a degradation of Phe will lead to the
depletion of stores of this essential amino acid and consequently a decrease in
protein synthesis.<span style="mso-spacerun: yes">  </span>Enzymes control the
levels of amino acids in the bloodstream, which can fluctuate widely due to
dietary intake.<span style="mso-spacerun: yes">  </span>In the case of Phe, the
degradative enzyme phenylalanine hydroxylase is the major enzyme for Phe
disposal, and is responsible for serum Phe levels.</p>

<p class=MsoBodyText2><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Phenylalanine hydroxylase, an
essential role<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Phenylalanine
hydroxylase (PheH; <a href="http://www.expasy.org/cgi-bin/nicezyme.pl?1.14.16.1"
title="ENZYME database entry for phenylalanine hydroxylase">EC 1.14.16.1</a>)
is an iron-dependent, tetrahydrobiopterin (BH<sub>4</sub>)-dependent
monooxygenase that catalyses the rate limiting step in the catabolism of
Phe.<span style="mso-spacerun: yes">  </span>PheH converts Phe into tyrosine
(Tyr) by hydroxylating Phe, using BH<sub>4</sub> as a reductant:</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width=609 bgcolor="#f3f3f3"
 style='width:456.75pt;background:#F3F3F3;border-collapse:collapse;mso-padding-alt:
 0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=148 style='width:110.8pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><!--[if gte vml 1]><v:shape
   id="_x0000_i1031" type="#_x0000_t75" style='width:59.25pt;height:104.25pt'
   o:ole="">
   <v:imagedata src="./Page1_files/image005.wmz" o:title=""/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=79 height=139
  src="./Page1_files/image006.gif" v:shapes="_x0000_i1031"><![endif]><!--[if gte mso 9]><xml>
   <o:OLEObject Type="Embed" ProgID="ChemDraw.Document.6.0"
    ShapeID="_x0000_i1031" DrawAspect="Content" ObjectID="_1166601790">
   </o:OLEObject>
  </xml><![endif]--></p>
  </td>
  <td width=104 style='width:77.7pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
  <td width=75 valign=bottom style='width:55.9pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <h3>PheH</h3>
  </td>
  <td width=136 valign=top style='width:101.8pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><!--[if gte vml 1]><v:shape
   id="_x0000_i1029" type="#_x0000_t75" style='width:59.25pt;height:135pt'
   o:ole="">
   <v:imagedata src="./Page1_files/image007.wmz" o:title=""/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=79 height=180
  src="./Page1_files/image008.gif" v:shapes="_x0000_i1029"><![endif]><!--[if gte mso 9]><xml>
   <o:OLEObject Type="Embed" ProgID="ChemDraw.Document.6.0"
    ShapeID="_x0000_i1029" DrawAspect="Content" ObjectID="_1166601791">
   </o:OLEObject>
  </xml><![endif]--></p>
  </td>
  <td width=147 style='width:110.55pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=148 style='width:110.8pt;background:#E6E6E6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>L&#8209;phenylalanine</p>
  </td>
  <td width=104 style='width:77.7pt;background:#E6E6E6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>+&nbsp;BH<sub>4</sub>&nbsp;+&nbsp;O<sub>2</sub></p>
  </td>
  <td width=75 style='width:55.9pt;background:#E6E6E6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  style='font-size:20.0pt;mso-bidi-font-size:12.0pt;font-family:Wingdings;
  mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
  mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span
  style='mso-char-type:symbol;mso-symbol-font-family:Wingdings'>à</span></span></b><b><span
  style='font-size:20.0pt;mso-bidi-font-size:12.0pt'><o:p></o:p></span></b></p>
  </td>
  <td width=136 style='width:101.8pt;background:#E6E6E6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>L&#8209;tyrosine</p>
  </td>
  <td width=147 style='width:110.55pt;background:#E6E6E6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>+&nbsp;4a&#8209;hydroxy&#8209;BH<sub>4</sub></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>PheH
is abundant in the liver, where it acts as a monooxygenase, incorporating one
molecule of oxygen into the amino acid substrate, while the other oxygen atom
is reduced to water using BH<sub>4</sub> as the reductant.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText2><span style='mso-tab-count:1'>            </span>PheH
occurs in both eukaryotic and prokaryotic species.<span style="mso-spacerun:
yes">  </span>In mammals, PheH occurs as homodimers and active homotetramers in
equilibrium.<span style="mso-spacerun: yes">  </span>Each monomer polypeptide
is composed of three domains:<span style="mso-spacerun: yes">  </span>an
N-terminal regulatory domain that contains an autoregulatory sequence (ARS) at
the N-terminus, a central catalytic core, and a short C-terminal
tetramerisation domain that contains an <span style='font-family:Symbol'>a</span>-helix
used to interlock the monomers.<span style="mso-spacerun: yes">  </span>The
catalytic core contains a hydrophobic “cage” that surrounds the aromatic,
hydrophobic Phe substrate.<span style="mso-spacerun: yes">  </span>The
N-terminal ARS physically blocks the entrance to the active site, and may
control access of both substrate and cofactors.<span style="mso-spacerun:
yes">  </span>The ARS may also interact with Phe substrate, BH<sub>4 </sub>cofactor
and catecholamine inhibitors to regulate PheH activation.</p>

<p class=MsoBodyText2><span style='mso-tab-count:1'>            </span>In
bacteria, PheH occurs as a monomer, consisting of only a single domain – the
catalytic core. There is no regulatory domain present, and consequently no
evidence of allosteric activation.<span style="mso-spacerun: yes">  </span>In
bacteria, Phe is not an essential amino acid, but is synthesised.</p>

<p class=MsoBodyText2><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Enzyme Control<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>PheH controls
the rate of Phe catabolism, and indirectly the rate of protein and
neurotransmitter biosynthesis.<span style="mso-spacerun: yes">  </span>In
addition, the metabolites of Phe degradation are toxic to the developing brain;
therefore, PheH must be under strict regulatory control in eukaryotes, despite
fluctuations in dietary intake.<span style="mso-spacerun: yes">  </span>PheH is
regulated in three main ways:<span style="mso-spacerun: yes">  </span>BH<sub>4</sub>
cofactor inhibition, substrate activation, and phosphorylation. </p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>In addition to
being an essential co-substrate for catalysis, the BH<sub>4</sub> cofactor
helps regulate the enzyme.<span style="mso-spacerun: yes">  </span>The binding
of the BH<sub>4</sub> cofactor at the active site results in a PheH&#8209;BH<sub>4</sub>
complex that inhibits both substrate activation by Phe and phosphorylation of
the enzyme, possibly by pulling the ARS region further into the active site to
block it.<span style="mso-spacerun: yes">  </span>Furthermore, BH<sub>4</sub>
may be important for enzyme stability, shielding the active site against damage
by reactive oxygen species.</p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>Activation by
its substrate, Phe, is a reversible process that involves all subunits of the
tetramer.<span style="mso-spacerun: yes">  </span>Phe can bind at two sites,
the active site where it undergoes hydroxylation, and an allosteric site where
it regulates PheH activation.<span style="mso-spacerun: yes">  </span>The
binding of Phe induces both local and global conformational changes in the
enzyme, which displace the BH<sub>4</sub> cofactor bound at the active
site.<span style="mso-spacerun: yes">  </span>The displacement of the BH<sub>4</sub>
cofactor releases its interaction with the ARS, which displaces the ARS from
the active site as well as exposing it to phosphorylation.</p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>Phosphorylation
of PheH by cAMP-dependent protein kinase (PKA) involves a single serine
residue, Ser16, in the N-terminal ARS region.<span style="mso-spacerun: yes"> 
</span>Phosphorylation of Ser16 induces a conformational change in the ARS
region and in the Phe-binding region of the active site.<span
style="mso-spacerun: yes">  </span>These conformational changes permit greater
accessibility of Phe to the active site by displacing the ARS, as well as
increasing the binding affinity of the active site for Phe.<span
style="mso-spacerun: yes">  </span>In this way, phosphorylation acts as a
conformational switch that facilitates Phe-driven PheH activation.<span
style="mso-spacerun: yes">  </span>The activation of PheH is a cooperative
process, where the subsequent binding of Phe serves to increase the rate of
PheH phosphorylation, driving the activation of the enzyme.<span
style="mso-spacerun: yes">  </span>By contrast, the binding of the BH<sub>4</sub>
cofactor inhibits phosphorylation.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='tab-stops:114.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page2.htm">Phenylketonuria, Loss of
Control</a><o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
